AI Verdict
PAYS has stronger fundamentals based on our AI analysis.
PBH vs PAYS Fundamental Comparison
| Metric | PBH | PAYS |
|---|---|---|
| Revenue | $807.1M | $82.0M |
| Net Income | $136.4M | $7.6M |
| Net Margin | 16.9% | 9.2% |
| ROE | 7.5% | 15.6% |
| ROA | 3.9% | 2.7% |
| Current Ratio | 3.11x | 1.11x |
| Debt/Equity | 0.56x | 0.13x |
| EPS | $2.78 | $0.13 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PBH vs PAYS: Frequently Asked Questions
Is PBH or PAYS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PAYS has stronger fundamentals. PBH is rated BUY (65% confidence) while PAYS is rated BUY (78% confidence). This is not investment advice.
How does PBH compare to PAYS fundamentally?
Prestige Consumer Healthcare Inc. has ROE of 7.5% vs Paysign, Inc.'s 15.6%. Net margins are 16.9% vs 9.2% respectively.
Which stock pays higher dividends, PBH or PAYS?
PBH has a dividend yield of N/A or no dividend while PAYS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PBH or PAYS for long term?
For long-term investing, consider that PBH has BUY rating with 65% confidence, while PAYS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PBH vs PAYS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PBH vs PAYS, the AI consensus favors PAYS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.